Winning Stock Forecast: Biopharma Company Amarin Corporation PLC (NASDAQ: AMRN) Brings 16.01 % In 7 Days

October 28, 2018

AMRN Winning Stock Forecast

Source: kisspng.com

This week biopharma company AMRN saw a 16.01 % jump, being the 7 day forecast’s biggest earner, as the I Know First algorithm predicted. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid. Heart Disease is still the leading factor for deaths in the USA and following recent patient trials Vascepa users are 25% less likely to suffer from a cardiac arrest. These impressive results thrust Vascepa as the industry leader drug for those suffering with high

Winning Stock Forecast

Winning Stock Forecast: The Brasilian Gol Transportes Aéreos (NYSE: GOL) Brings 20.93% In 3 Days

October 21, 2018

By Gol Airlines [Public domain], via Wikimedia Commons

GOL is a young company, established in 2000, serves more then 30 million passengers annually with 67 destination and 10 countries in South America and Caribbean. Moreover, it is a leading cargo transportation and logistics business serving more than 3,400 Brazilian municipalities and, through partners, more than 200 international destinations in 95 countries.

In the end of August 2018, as part of the strategic program to renew the equipment GOL welcomed the Boeing 737MAX, the first Boieng jet in history of the company. This aircraft will

Winning Stock Forecast

Winning Stock Forecast: Top Performers In The Long (AMD) & Short (PTLA) Position After 3 Months

October 15, 2018

Winning AMD & PTLA Forecast

Three months ago, I Know First’s predictive algorithm conducted a forecast that would predict the success of the top stock picks of both bullish and bearish positions. For the long positions, the largest growth was registered by AMD with a return of 61.74%. The package itself which consisted of 5 overall picks in the long position, had an overall average return of 19.20%, providing a premium of 14.68% over the SP500’s return of 4.52%. The best performance in the short position came from PTLA which registered a return of 40.77%. With regards to the forecasted stocks

Winning Stock Forecast

Winning Stocks Forecast: CUV.AX & YOW.AX bring highest returns from Australian stock market

October 9, 2018

Winning Stocks Forecast

Clinuvel Pharmaceuticals Limited (CUV.AX)

Source: biotech-capital.com

Over the past month Clinuvel Pharmaceuticals Limited (CUV.AX) saw a rise of 49.19% this marks it as the biggest earner within Australian Stock as I Know First predicted. This surge can be attributed to the anticipated FDA approval for its drug SCENESSE® a photo-protective drug used to treat a rare condition known as targeting erythropoietic protoporphyria (EPP). SCENESSE® is already approved by the EU in 2014 and was available from 2016 across Europe. In the first half of FY18, Clinuvel had revenue of just $7 million, enough to generate

Winning Stock Forecast

Winning AMD & DDD Stock Forecast: The Biggest Of Tech Giants After Three Months

October 3, 2018

Winning AMD Stock Forecast

(By AMD via Wikimedia Commons)

In conjunction with I Know First’s 3 month algorithmic forecast, the top earner was AMD. The chipmakers’ saw increases of 106.35% at the conclusion of those months. The company that was once in big trouble has been on quite an incline. For 2018, AMD announced Q1 earnings of $1.65 billion, exceeding that with Q2 earnings of $1.76 billion. After increases in quality product, they are once again giving competitors NVDA and INTC

Winning Stock Forecast

Winning Stock Forecast: Acadia, Protalix Bring Big Returns In The BioTech Space

September 27, 2018

ACAD Winning Stock Forecast

By Pöllö -commons.wikimedia.org

This week ACAD saw a 52.38% jump, being the 7 day forecast’s biggest earner, as the I Know First algorithm predicted. Before this week, ACAD’s shares have been under pressure from what turned out to be an inaccurate report from CNN. Acadia Pharmaceuticals is again bringing in impressive returns. The drug under fire was Nuplazid. The FDA only recently discarded these allegations to be untrue. Nuplazid made up $57.1 million in sales Q2 for ACAD, an 18% increase from the first quarter. Sales of the drug are increasing 87% year over year. The

Winning Stock Forecast

Winning AMD Stock Forecast (NASDAQ: AMD): Chip Maker AMD Continues To Surge The Market

September 21, 2018

Winning AMD Stock Forecast

AMD’s Ryzen Close Up. By Fritzchens Fritz from Berlin (via WikiMediaCommons/Public Domain)

Advanced Micro Devices Inc. (AMD) went from a company that was once in fair amount of trouble, to a competitor against giants Nvidia and Intel. Shares have been seeing a continuous rise, reaching a 12-year high. The stock rose 200% this past month alone. AMD’s Ryzen microprocessors can take a fair amount of credit for this success. That along with quality leadership with Lisa Su as CEO. Ryzen outperforms competitor Intel’s comparable chips, and at a lower price. The same outperformance